Barclays’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $222K | Buy |
156,337
+37,336
| +31% | +$53K | ﹤0.01% | 3462 |
|
|
2025
Q1 | $182K | Buy |
119,001
+103,800
| +683% | +$159K | ﹤0.01% | 3383 |
|
|
2024
Q4 | $38K | Sell |
15,201
-5,192
| -25% | -$13K | ﹤0.01% | 4006 |
|
|
2024
Q3 | $23K | Sell |
20,393
-19,852
| -49% | -$22.4K | ﹤0.01% | 4047 |
|
|
2024
Q2 | $44K | Sell |
40,245
-28,021
| -41% | -$30.6K | ﹤0.01% | 3711 |
|
|
2024
Q1 | $85K | Sell |
68,266
-107,653
| -61% | -$134K | ﹤0.01% | 3694 |
|
|
2023
Q4 | $184K | Sell |
175,919
-58,231
| -25% | -$60.9K | ﹤0.01% | 3536 |
|
|
2023
Q3 | $1.6M | Buy |
234,150
+148,761
| +174% | +$1.02M | ﹤0.01% | 1791 |
|
|
2023
Q2 | $885K | Sell |
85,389
-3,301
| -4% | -$34.2K | ﹤0.01% | 2230 |
|
|
2023
Q1 | $717K | Buy |
88,690
+45,880
| +107% | +$371K | ﹤0.01% | 2366 |
|
|
2022
Q4 | $674K | Buy |
42,810
+26,103
| +156% | +$411K | ﹤0.01% | 2396 |
|
|
2022
Q3 | $263K | Sell |
16,707
-5,262
| -24% | -$82.8K | ﹤0.01% | 2942 |
|
|
2022
Q2 | $307K | Sell |
21,969
-38,287
| -64% | -$535K | ﹤0.01% | 2887 |
|
|
2022
Q1 | $1.04M | Sell |
60,256
-40,262
| -40% | -$694K | ﹤0.01% | 2275 |
|
|
2021
Q4 | $1.46M | Buy |
100,518
+50,349
| +100% | +$732K | ﹤0.01% | 1976 |
|
|
2021
Q3 | $903K | Buy |
50,169
+38,402
| +326% | +$691K | ﹤0.01% | 2309 |
|
|
2021
Q2 | $205K | Buy |
11,767
+11,749
| +65,272% | +$205K | ﹤0.01% | 2880 |
|
|
2021
Q1 | $0 | Hold |
18
| – | – | ﹤0.01% | 3894 |
|
|
2020
Q4 | $0 | Hold |
18
| – | – | ﹤0.01% | 3516 |
|
|
2020
Q3 | $0 | Sell |
18
-8,276
| -100% | – | ﹤0.01% | 3705 |
|
|
2020
Q2 | $13K | Sell |
8,294
-2,222
| -21% | -$3.48K | ﹤0.01% | 3612 |
|
|
2020
Q1 | $11K | Sell |
10,516
-73,337
| -87% | -$76.7K | ﹤0.01% | 3472 |
|
|
2019
Q4 | $159K | Buy |
83,853
+66,735
| +390% | +$127K | ﹤0.01% | 3278 |
|
|
2019
Q3 | $18K | Sell |
17,118
-5,897
| -26% | -$6.2K | ﹤0.01% | 3857 |
|
|
2019
Q2 | $50K | Buy |
23,015
+12,532
| +120% | +$27.2K | ﹤0.01% | 3827 |
|
|
2019
Q1 | $63K | Buy |
+10,483
| New | +$63K | ﹤0.01% | 3545 |
|
|
2018
Q4 | – | Sell |
-12,243
| Closed | -$178K | – | 4066 |
|
|
2018
Q3 | $178K | Buy |
12,243
+10,279
| +523% | +$149K | ﹤0.01% | 3130 |
|
|
2018
Q2 | $39K | Sell |
1,964
-4,414
| -69% | -$87.7K | ﹤0.01% | 3375 |
|
|
2018
Q1 | $111K | Buy |
6,378
+1,846
| +41% | +$32.1K | ﹤0.01% | 3126 |
|
|
2017
Q4 | $112K | Sell |
4,532
-2,925
| -39% | -$72.3K | ﹤0.01% | 2947 |
|
|
2017
Q3 | $192K | Buy |
7,457
+6,904
| +1,248% | +$178K | ﹤0.01% | 2407 |
|
|
2017
Q2 | $15K | Sell |
553
-5,055
| -90% | -$137K | ﹤0.01% | 3340 |
|
|
2017
Q1 | $167K | Buy |
5,608
+258
| +5% | +$7.68K | ﹤0.01% | 2598 |
|
|
2016
Q4 | $145K | Buy |
5,350
+5,197
| +3,397% | +$141K | ﹤0.01% | 2451 |
|
|
2016
Q3 | $4K | Buy |
+153
| New | +$4K | ﹤0.01% | 3449 |
|
|
2016
Q1 | – | Sell |
-1,000
| Closed | -$26K | – | 3429 |
|
|
2015
Q4 | $26K | Buy |
+1,000
| New | +$26K | ﹤0.01% | 2646 |
|